Stabilized soluble pre-fusion RSV F polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10899800
APP PUB NO 20160102123A1
SERIAL NO

14786955

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are stable pre-fusion respiratory syncitial virus (RSV) F polypeptides, immunogenic compositions comprising the polypeptides and uses thereof for the prevention and/or treatment of RSV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN VACCINES & PREVENTION B V2333 CN LEIDEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Krarup, Anders Leiden, NL 9 58
Langedijk, Johannes Petrus Maria Leiden, NL 44 181

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 26, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 26, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00